Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam flag Vietnam · Delayed Price · Currency is VND
145,200
0.00 (0.00%)
At close: Feb 3, 2026

HNX:PMC Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
546,567498,185485,186472,274414,232
Revenue Growth (YoY)
9.71%2.68%2.73%14.01%-10.10%
Cost of Revenue
323,367310,972315,134285,918266,740
Gross Profit
223,200187,213170,053186,356147,492
Selling, General & Admin
121,12096,72985,64595,58874,912
Other Operating Expenses
4,180----
Operating Expenses
125,30096,72985,64595,58874,912
Operating Income
97,90090,48484,40890,76872,580
Interest Expense
-302.47----
Interest & Investment Income
3,8529,55719,85313,1789,363
Currency Exchange Gain (Loss)
1.282.3717.19-43.0227.29
Other Non Operating Income (Expenses)
452.42269.41148.96-675.76-1,022
EBT Excluding Unusual Items
101,903100,313104,427103,22780,949
Gain (Loss) on Sale of Assets
1,202-175.451,253334.97
Other Unusual Items
-105.17----
Pretax Income
102,999100,313104,602104,48081,284
Income Tax Expense
20,69520,18021,03821,06416,524
Net Income
82,30580,13383,56483,41664,760
Preferred Dividends & Other Adjustments
-21,63622,56222,52217,485
Net Income to Common
82,30558,49761,00260,89447,275
Net Income Growth
2.71%-4.11%0.18%28.81%-13.21%
Shares Outstanding (Basic)
99999
Shares Outstanding (Diluted)
99999
EPS (Basic)
8819.106268.076536.476524.895065.55
EPS (Diluted)
8819.106268.006536.006524.895065.55
EPS Growth
40.70%-4.10%0.17%28.81%-13.21%
Free Cash Flow
-58,93239,22786,67831,67558,885
Free Cash Flow Per Share
-6314.624203.239287.653394.026309.63
Dividend Per Share
-2400.00019100.0003000.0002400.000
Dividend Growth
--87.44%536.67%25.00%-
Gross Margin
40.84%37.58%35.05%39.46%35.61%
Operating Margin
17.91%18.16%17.40%19.22%17.52%
Profit Margin
15.06%11.74%12.57%12.89%11.41%
Free Cash Flow Margin
-10.78%7.87%17.87%6.71%14.21%
EBITDA
109,758101,75596,345103,31186,549
EBITDA Margin
20.08%20.42%19.86%21.88%20.89%
D&A For EBITDA
11,85811,27111,93812,54313,968
EBIT
97,90090,48484,40890,76872,580
EBIT Margin
17.91%18.16%17.40%19.22%17.52%
Effective Tax Rate
20.09%20.12%20.11%20.16%20.33%
Revenue as Reported
546,567498,185485,186472,274414,232
Source: S&P Global Market Intelligence. Standard template. Financial Sources.